人类增强剂突变发生敏感性的体内测绘
Michael Kosicki1, Boyang Zhang2, Vivian Hecht2
1Environmental Genomics & System Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Nature
|June 18, 2025
概括
人类发育增强剂具有许多关键序列特征,这些特征对于功能至关重要. 这项研究绘制了这些特征,揭示了大多数突变破坏了增强剂活性,有助于疾病基因解释.
科学领域:
- 遗传学
- 发育生物学
- 分子生物学
背景情况:
- 远程增强剂对于人类的发展至关重要.
- 了解增强剂序列特征对于解释疾病相关突变至关重要.
研究的目的:
- 在体内确定人类发育增强剂对突变发生的功能敏感性.
- 在基对分辨率下绘制增强剂内的关键核酸.
主要方法:
- 产生了1700多只转基因小鼠,
- 在增强剂中发生系统突变的12个块.
- 使用预测模型和机器学习来识别功能动机.
主要成果:
- 在69%的突变块中需要正常的体内增强剂活性.
- 突变更常导致功能丧失 (60%) 而非功能增长 (9%).
- 机器学习模型准确地预测了88%的功能模式,并确定了59%的功能障碍.
结论:
- 人类增强剂具有高密度的序列特征,对体内功能至关重要.
- 这项工作为了解增强剂功能和疾病机制提供了资源.
- 这些发现有助于解释人类遗传疾病中的增强器突变.
相关概念视频
01:16In-vitro Mutagenesis
14.2K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.2K
01:25Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K